메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Travelers from Singapore Can Now Access 24/7 Multilingual O…

TOKYO, Nov. 13, 2025 -- HOTEL de DOCTOR 24, a specialized online medical consultation service provided by M3 Career, Inc., offers seamless 24-hour access to healthcare for international travelers facing difficulties obtaining medical care in Japan. While HOTEL de DOCTOR 24 has been available in Japan since April 2025 -- and already used by travelers from Singapore -- this marks the first official introduction of the service to the Singapore market, ensuring that future visitors can access trusted medical support during their stay in Japan. Image: https://cdn.kyodonewsprwire.jp/prwfile/
- 김갑성 기자
- 2025-11-13 15:00
Agilent and National Heart Centre Singapore Sign Agreement…

[ 메디채널 김갑성 기자 ] Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE, Nov. 13, 2025 -- Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (NHCS) to accelerate innovation in metabolic heart failure research, one of the most complex and underserved areas in cardiovascular medicine. Agilent Seahorse XF Flex Analyzer 3D Workflow Features Metabolic Profile
- 김갑성 기자
- 2025-11-13 12:05
Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCAR…

[ 메디채널 김갑성 기자 ] - 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 13, 2025 -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue of KRW 10.8 billion, operating profit of KRW 1.0 billion, and net profit of KRW 1.0 billion. Revenue rose approximately 58% year-on-year (YoY) from KRW 6.9 billion in the same period last year and 17% quarter-on-quarter (QoQ) from KRW 9.3 billion in Q2. With this, VUNO has achieved 11 consecutive
- 김갑성 기자
- 2025-11-13 09:47
Ascletis Announces Co-formulation of ASC36, Once-Monthly N…

- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinetic (PK) profile to ASC36 and ASC35 dosed alone in head-to-head non-human primate studies. - ASC36 monotherapy demonstrated approximately 32% greater relative body weight reduction compared to eloralintide monotherapy in a head-to-head diet-induced obese (DIO) rat study, while ASC35 monotherapy
- 김갑성 기자
- 2025-11-13 07:30
Laronix Secures $3.2 Million Grant from the Australian Governm…

BRISBANE, Australia, Nov. 13, 2025 -- Laronix, ("Laronix" or the "Company"), a commercial-stage medical technology (MedTech) company and an industry-leading innovator in voice restoration technologies, today announced that it has been awarded AUD $3.2 million (approximately USD $2.1 million) in non-dilutive funding from the Australian Government's Industry Growth Program (IGP 2025). Farzaneh Ahmadi, PhD, Chief Executive Officer of Laronix, said, "Human voice loss is a largely unattended global health problem afflicting millions of patients every year. L
- 김갑성 기자
- 2025-11-13 06:30
TCab Tech Secures RMB 300 Million in Series B++ Funding to Po…

SHANGHAI, Nov. 12, 2025 -- The leading electric vertical take-off and landing (eVTOL) firm, TCab Tech, has announced the completion of its RMB 300 million (approx. USD 43 million) Series B++ funding round, jointly invested by Meridian Capital, HuaHan Capital, and Puhua Capital. This is TCab Tech's second funding round completed in 2025 and the seventh since its founding, bringing the company's total funding to over RMB 1 billion (approx. USD 143 million). This funding marks the first major investment in China's low-altitude economy sector since the industry was designated as a
- 김갑성 기자
- 2025-11-12 22:21
Starwood Pet Travel Reports 800% Growth in Pet Relocations Lin…

CAPE CORAL, Fla., Nov. 13, 2025 -- Starwood Pet Travel, a global leader in international pet relocation, has reported an 800% increase in relocations since 2019, driven in part by a surge of doctors, nurses, and other medical professionals moving to New Zealand with their pets. According to the Medical Council of New Zealand, internationally trained doctors currently make up more than 43% of New Zealand's medical workforce, and over 70% of all new doctor registrations in the year ending June 2024 were overseas-trained. For nursing, the Nursing Council of New Zealand repo
- 김갑성 기자
- 2025-11-12 22:00
Waters, Empower 소프트웨어용 하전 에어로졸 검출기 출시로 실험실 생산성과 샘플…

세계적 수준의 Empower™ 크로마토그래피 데이터 시스템(CDS)과 원활하게 통합되어 품질 관리 및 개발 환경의 효율성과 신뢰성을 향상시킵니다. 멀티벤더 LC-CAD 구성에서 최대 70%까지 발생하는 CDS 통신 오류를 완화합니다.[1] 광범위한 분석대상 화합물 전체에 거의 보편적으로 검출을 가능하게 하며, UV 또는 질량 분석법으로 측정하기 어려운 물질을 포함하여 제약 제형, 식품 첨가물 및 환경 오염 물질의 광범위한 분석 물질에 대해 거의 보편적인 검출 기능을 제공합니다. 매사추세츠주 밀퍼드, 2025년 11월 12일 -- Waters Corporation (NYSE:WAT)은 오늘, 세계적으로 가장 신뢰받는 크로마토그래피 데이터 시스템(CDS)인 Waters Empower 소프트웨어와의 완벽한 호환을 위해 설계된 하전 에어로졸 검출기(Charged Aerosol Detector, CAD)를 새롭게 출시했다고 발표했습니다. Waters는 규제 당국에 크로마토그래피 소프트웨어 솔루션의 글로벌 시장 리더이며, Empower 소프트웨어는 전체 신약의 약 80%에 대한 데이터를 규제 기관에 제출하는 데 사용됩니다.[
- 김갑성 기자
- 2025-11-12 08:00
MGI Tech Joins Forces with SAMRC and DSTI to Launch South…

CAPE TOWN, South Africa, Nov. 11, 2025 -- MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced two historic milestones in African genomics: the official unveiling of the continent's first DNBSEQ-T7 sequencing platform at the South African Medical Research Council (SAMRC), and the signing of a Memorandum of Understanding (MoU) between MGI, the Department of Science, Technology and Innovation (DSTI), and the SAMRC to launch the 110K Human Genome Program in South Africa. These milestones represent a trans
- 김갑성 기자
- 2025-11-11 17:40
Apollo Cancer Centres Turns Chocolates into Health Remind…

NEW DELHI, Nov. 11, 2025 -- To observe this year's Breast Cancer Awareness Month, Apollo Cancer Centres (ACCs) recently launched across India a unique initiative that blended indulgence with awareness through 'Check-Olate', a sweet treat that carries an even sweeter reminder: take a moment for yourself. Breast cancer is one of the major public health challenges worldwide. GLOBOCAN data indicates approximately 2.3 million new female breast cancer cases worldwide. Recognising the urgent need for greater awareness and proactive prevention, ACCs aimed to normalise self-care
- 김갑성 기자
- 2025-11-11 17:15

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 10일 21시 20분